life sciences - In this Modern Industrial Strategy, the government says it will unleash the economic potential of Life Sciences clusters, including London, Oxford and Cambridge, as well as other clusters in Manchester, Liverpool, Yorkshire, South Wales, the North East, West Midlands and the Glasgow Edinburgh-Dundee triangle. - The Modern Industrial Strategy sets out the government’s aim to make the UK one of the world’s top three Life Sciences economies through a package of reforms and investment, including up to £600m for a Health Data Research Service to create the world’s most advanced, secure and AI-ready health data platform. - Prioritising high-growth frontier life sciences industries, including pharmaceuticals, driven by a strong ecosystem for branded, generic and biosimilar medicines and MedTech, supported by both major firms and growing SMEs. - The Life Sciences Sector Plan will be supported over the lifetime of the Spending Review by public funding of over £2bn, alongside funding from UK Research and Innovation (UKRI) and the National Institute for Health and Care Research (NIHR). - The Office for Life Sciences is speeding up negotiations for science investments over £250m via the introduction of a Life Sciences Large Investment Portfolio, providing investors with upfront clarity over the UK’s offer and bespoke, structured engagement through negotiations.
Made with FlippingBook interactive PDF creator